Emily Mahoney is an experienced attorney currently serving at Deciphera Pharmaceuticals since September 2024. Prior roles include Senior Corporate Counsel at Affinia Therapeutics from September 2021 to August 2024, and Assistant General Counsel for R&D at Ipsen for a brief period in 2021. Mahoney's legal career began at Faber Daeufer & Itrato PC, where counsel duties were performed from August 2013 to April 2021. Additional consultancy work took place at Deloitte in 2013, along with several legal internships at prestigious organizations. Educational qualifications include a Master of Public Health from Tufts University School of Medicine, a Doctor of Law from Northeastern University School of Law, and a Bachelor of Arts from Washington University in St. Louis.